Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 41

Trial Status

Completed6

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Profil Institute for Clinical Research, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Roman Hovorka, PhD

University of Cambridge

Moderately Similar
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes MellitusDiabetes Mellitus, Type 2+1 more
Similarity Score30%

Klas Malmberg, MD, PhD, Prof

AstraZeneca R&D Mölndal

Related
3 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score24%

Bruce Bode, MD

Atlanta Diabetes Associates

Related
8 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Hypoglycemia
Similarity Score23%

Timothy Bailey, MD

AMCR Institute

Related
19 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

AMCR Institute
Similarity Score23%

Mustafa H Temel, M.D.

Uskudar State Hospital

Related
23 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score23%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 2
Similarity Score15%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score15%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

AstraZeneca
Similarity Score15%

Bruce Buckingham, MD

Stanford University

Related
24 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus
Similarity Score15%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 2
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00790153Phase 1PrincipalInvestigator

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Type 2 Diabetes
Completed
NCT01221545Phase 1PrincipalInvestigator

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients

Type 2 Diabetes Mellitus
Completed
NCT01275131Phase 1PrincipalInvestigator

Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes Mellitus
Completed
NCT01526733Phase 4PrincipalInvestigator

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Type 1 Diabetes Mellitus
Completed
NCT02345967Not ApplicablePrincipalInvestigator

Function of Implanted Glucose Sensor 2

Diabetes Mellitus
Completed
NCT02403648Phase 1PrincipalInvestigator

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

Hypoglycemia
Completed

All 6 trials loaded